Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

Correlates of preclinical cardiovascular disease in Indigenous and Non-Indigenous Australians: a case control study

Brian A Haluska email, Lionel Chan email, Leanne Jeffriess email, A Andrew Shaw email, Joanne Shaw email and Thomas H Marwick email

School of Medicine, University of Queensland, Brisbane, Australia

author email corresponding author email

Cardiovascular Ultrasound 2008, 6:36doi:10.1186/1476-7120-6-36

Published: 16 July 2008

Abstract

Background

The high frequency of premature death from cardiovascular disease in indigenous Australians is often attributed to the high prevalence of risk factors, especially type II diabetes mellitus (DM). We evaluated the relationship of ethnicity to atherosclerotic burden, as evidenced by carotid intima-media thickness (IMT), independent of risk factor status.

Methods

We studied 227 subjects (147 men; 50 ± 13 y): 119 indigenous subjects with (IDM, n = 54), and without DM (InDM, n = 65), 108 Caucasian subjects with (CDM, n = 52), and without DM (CnDM, n = 56). IMT was measured according to standard methods and compared with clinical data and cardiovascular risk factors.

Results

In subjects both with and without DM, IMT was significantly greater in indigenous subjects. There were no significant differences in gender, body mass index (BMI), systolic blood pressure (SBP), or diastolic blood pressure (DBP) between any of the groups, and subjects with DM showed no difference in plasma HbA1c. Cardiovascular risk factors were significantly more prevalent in indigenous subjects. Nonetheless, ethnicity (β = -0.34; p < 0.0001), age (β = 0.48; p < 0.0001), and smoking (β = 0.13; p < 0.007) were independent predictors of IMT in multiple linear regression models.

Conclusion

Ethnicity appears to be an independent correlate of preclinical cardiovascular disease, even after correction for the high prevalence of cardiovascular risk factors in indigenous Australians. Standard approaches to control currently known risk factors are vital to reduce the burden of cardiovascular disease, but in themselves may be insufficient to fully address the high prevalence in this population.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.